This continuing education is designed to enhance the knowledge of healthcare participants with:

1. Epidemiology, pathophysiology, current risk reduction strategies, and evidence based management of disease conditions such as Stroke, Laryngeal Cancer, Obstructive Sleep Apnea, Acute Coronary Syndrome, Metabolic Syndrome, Trauma and other Dermatological Conditions/Procedures.
2. Bioethical considerations of victims of cardiopulmonary arrest.
3. Cardiovascular risk reduction strategies including hypertension, dyslipidemia, diabetes mellitus, obesity.

STROKE

At the end of the course, the participant will be able to:

1. Define stroke.
2. Differentiate the types of stroke.
3. Identify the causes of stroke.
4. Discuss Transient Ischemic Attack.
5. Recognize the signs and symptoms of stroke.
6. State the effects of stroke.
7. Name the risk factors of stroke.
8. Describe the pathway to success in management of stroke.
9. Utilize the diagnostic tools of acute stroke.
10. Compare the diseases that mimic stroke.
11. Describe the NIH Stroke Scale.
12. Name the approaches to acute therapy.
13. List the clinical studies related to stroke.
14. Discuss the benefits of rehabilitation in stroke patients.

 

OBSTRUCTIVE SLEEP APNEA

At the end of the course, the participant will be able to:

1. Define Obstructive Sleep Apnea
2. Compare the types of Obstructive Sleep Apnea.
3. Discuss the epidemiology of OSA.
4. Describe the pathogenesis of OSA.
5. List the predisposing factors of OSA.
6. Name the risk factors of OSA.
7. Identify the diagnostic tool for OSA.
8. State the signs and symptoms of OSA.
9. Discuss the investigational studies of OSA.
10. Differentiate the level of severity of OSA.
11. Describe the management of OSA.

 

LARYNGEAL CANCER

At the end of the course, the participant will be able to:

1. Discuss the incidence of laryngeal cancer.
2. List the risk factors of laryngeal cancer.
3. Identify the signs and symptoms of laryngeal cancer.
4. Define the American Joint Committee on Cancer TNM System.
5. Compare the AJCC Stage groupings of cancer.
6. Differentiate supraglottis, glottis, Regional lymph nodes, and distant metastasis.
7. Describe the nursing and medical management of laryngeal cancer according to stages.
8. List the evidenced based management of laryngeal cancer.

 

MEET THE CHALLENGE OF CARDIOVASCULAR RISK REDUCTION STRATEGIES

At the end of the course, the participant will be able to:

1. Discuss the epidemiology, prevalence, burden, and cost of cardiovascular disease.
2. Identify the established and emerging risk factors for cardiovascular disease.
3. Discuss the guidelines on management of hypertension and dyslipidemia.
4. List the pharmacologic and non-pharmacologic strategies to reduce cardiovascular risks.

 

BIOETHICAL CONSIDERATIONS IN CRITICAL CARE AND CARDIOPULMONARY RESUSCITATION

At the end of the course, the participant will be able to:

1. List the CPR goals.
2. Describe the ethical considerations In management of critically ill patients and victims of cardiopulmonary arrest.
3. Differentiate Advanced Directives and Living Will, Informed consent and informed decision.
4. Discuss the Patient self Determination Act of 1991.
5. Name the responsibilities of surrogate decision makers.
6. Discuss the importance of Bioethics Committee in the hospital.
7. Name the two principles of futility.
8. Describe the rate of survival timeline of patients in cardiopulmonary arrest.
9. Identify the irreversible signs of death.
10. List the factors affecting prognosis based on well designed studies.
11. Enumerate the criteria for not starting CPR, terminating resuscitation efforts, and DNAR.
12. Compare the levels of care in terms of Resuscitation in the hospital.

 

ACNE VULGARIS

At the end of the course, the participant will be able to:

1. Define Acne Vulgaris & Acne Scars.
2. Discuss the pathophysiology of Acne Vulgaris.
3. State the laboratory and diagnostic tests for Acne Vulgaris.
4. Describe myths about Acne Vulgaris.
5. Identify the pharmacological and non-pharmacological treatment of Acne Vulgaris and Acne Scars.
6. List the different types of Acne Scars.
7. Demonstrate the acute skin care guidelines.

 

PHOTOPROTECTION AND TOPICAL ANTIOXIDANTS

At the end of the course, the participant will be able to:

1. Discuss the 4 principles of photoprotection.
2. List the factors influencing the effectiveness of sunscreens.
3. Discuss the topical sunscreens and their basis for recommendations.
4. Name the biological facts about sunbathing and tanning.
5. Compare the different sunscreen chemicals.
6. Describe the adverse effects of sun protective agents.
7. Discuss the topical antioxidants and its indications.
8. List the management of sunburns.

 

EMERGENCY MANAGEMENT OF TRAUMA PATIENTS

At the end of the course, the participant will be able to:

1. List the objectives of Advanced Trauma Life Support.
2. Discuss the history of ATLS.
3. Discuss the trimodal death distribution.
4. Describe the airway maintenance with cervical spine protection, circulation with hemorrhage control.
5. List the adjuncts to primary survey and resuscitation.
6. Identify the diagnostic and x ray studies of trauma patients.
7. Name the key principle of monitoring the trauma patients.
8. Differentiate the primary and secondary survey of Trauma Life Support.
9. Describe the mechanism of injury and the suspected injury pattern.
10. Demonstrate how to perform the physical assessment of trauma patients.
11. Review the Glasgow Coma neurological assessment of trauma patients.
12. Discuss the nursing and medical management of trauma patients.
13. Describe the legal and ethical considerations in the care of trauma patients.

 

NEWBORN SCREENING REVISITED

At the end of the course, the participant will be able to:

1. Discuss the inborn errors of metabolism.
2. Differentiate the diseases of intoxication and diseases of fatty acid oxidation.
3. Describe the brief history of Newborn Screening.
4. Describe congenital adrenal hyperplasia.
5. Discuss the pathophysiology of congenital adrenal hyperplasia
6. Identify the signs and symptoms of congenital hyperplasia.
7. Enumerate the treatments of congenital hyperplasia.
8. Describe the Congenital hypothyroidism.
9. List the causes, signs and symptoms of congenital hypothyroidism.
10. Discuss galactosemia.
11. Name the causes of galactosemia.
12. Discuss the pathophysiology, signs and symptoms, and treatments of galactosemia.
13. Discuss the Glucose 6Phosphate Dehydrogenase.
14. Discuss the prevalence, causes, pathophysiology of G6PD disease.
15. Discuss causes, pathopysiology, and signs and symptoms of phenylketonuria.
16. List the treatments of PKU.
17. Identify the newborn screening flow of implementation.

 

METABOLIC SYNDROME

1. Discuss the definition of Metabolic Syndrome.
2. Discuss the prevalence of Metabolic Syndrome
3. Identify the core defect underlying Metabolic Syndrome.
4. Identify the risk Factors associated with Metabolic Syndrome.
5. List the clinical trials conducted on Metabolic Syndrome.
6. Identify the treatment goals for Metabolic Syndrome.
7. List the non-pharmacologic and pharmacologic intervention of Metabolic Syndrome.

 

end faq

• This Continuing Education is approved for 24.0 contact hours.
• Contact GAMI Office for registration and schedule.